Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated. The company's therapeutics target molecular pathways that drive the most aggressive and resistant forms of cancer using innovative mechanisms, enabling cancer patients to get their predictive biomarkers detected and get their treatments started from early stage.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 1, 2022 | Series C | $60M | 7 | Pfizer | — | Detail |
Oct 3, 2016 | Series A | $95M | 7 | ARCH Venture Partners Woodford Investment Management | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Pfizer | Yes | Series C |
Woodford Investment Management | Yes | Series A |
Evotec | — | Series C |
ARCH Venture Partners | — | Series C |
Cambridge Innovation Capital | — | Series C |
GV | — | Series C |
Lightstone Ventures | — | Series C |
Rosetta Capital | — | Series C |
University of Cambridge Enterprise | — | Series A |